2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EXPERT OPINION ON BIOLOGICAL THERAPY EXPERT OPIN BIOL TH (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
50人评分
我要评分
声誉 7.6 影响力 5.1 速度 7.0 | |||||||||||||||||||||||||||||||
期刊ISSN | 1471-2598 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 1744-7682 | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 3.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:2.491 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.2 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.61 | |||||||||||||||||||||||||||||||
h-index | 75 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://www.tandfonline.com/loi/iebt20#.V48Zckz9cSQ | |||||||||||||||||||||||||||||||
期刊投稿网址 | https://mc.manuscriptcentral.com/eobt | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足EXPERT OPINION ON BIOLOGICAL THERAPY的语言要求,还能让EXPERT OPINION ON BIOLOGICAL THERAPY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被EXPERT OPINION ON BIOLOGICAL THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||
通讯方式 | INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ | |||||||||||||||||||||||||||||||
出版商 | Taylor and Francis Ltd. | |||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-生物工程与应用微生物 | |||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||||||||||||
出版年份 | 2001 | |||||||||||||||||||||||||||||||
年文章数 | 92点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 19.17% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 48.91% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2598%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 一般,3-8周 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在EXPERT OPINION ON BIOLOGICAL THERAPY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Recent advances in stem cell therapy for erectile dysfunction: a narrative review Author: Wang, Bohan; Gao, Wenjun; Zheng, Micha Y.; Lin, Guiting; Lue, Tom F. Journal: EXPERT OPINION ON BIOLOGICAL THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14712598.2023.2203811 PubMed DOI |
2. | Comparing the pharmacokinetics, safety, and immunogenicity of HLX02 to US- and EU-approved trastuzumab in healthy Chinese male subjects: A Phase I, randomized, double-blind, parallel-group study Author: Zhou, Wenjia; Wang, Meng; Yu, Yunli; Wang, Ji; Wu, Yanni; Yang, Guiyu; Yu, Haoyu; Li, Jing; Zhou, Liang; Zhang, Quanying Journal: EXPERT OPINION ON BIOLOGICAL THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14712598.2023.2183117 PubMed DOI |
3. | Pharmacokinetics, pharmacodynamics, safety and immunogenicity of recombinant, fully human anti-RANKL monoclonal antibody (MW031) versus denosumab in Chinese healthy subjects: a single-center, randomized, double-blind, single-dose, parallel-controlled trial Author: Guo, Yinhan; Guo, Tingting; Di, Yujing; Xu, Wenyu; Hu, Zhitian; Xiao, Yanfeng; Yu, Heze; Hou, Jie Journal: EXPERT OPINION ON BIOLOGICAL THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14712598.2023.2178298 PubMed DOI |
4. | Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects Author: Zhang, Qin; Sun, Cheng; Wu, Jinying; Wu, Juan; Zhang, Xuan; Liu, Yueyue; Dou, Changlin; Qin, Huilin; Zhang, Qian; Zhou, Renpeng; Hu, Wei Journal: EXPERT OPINION ON BIOLOGICAL THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14712598.2023.2189009 PubMed DOI |
5. | Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis. Author: Mok CC, Tsai WC, Chen DY, Wei JC. Journal: Expert Opin Biol Ther. 2016;16(2):201-11. doi: 10.1517/14712598.2016.1118457. Epub 2015 Dec 2. PubMed |
6. | Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Author: Wang L, Hu J, Sorek CE, Chen EY, Ma PX, Yang B. Journal: Expert Opin Biol Ther. 2016;16(3):317-30. doi: 10.1517/14712598.2016.1118460. Epub 2015 Dec 8. PubMed |
7. | Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis. Author: Brar K, Leung DY. Journal: Expert Opin Biol Ther. 2016;16(4):507-14. doi: 10.1517/14712598.2016.1135898. Epub 2016 Mar 3. PubMed |
8. | Gene therapy strategies to improve strength and quality of flexor tendon healing. Author: Tang JB, Zhou YL, Wu YF, Liu PY, Wang XT. Journal: Expert Opin Biol Ther. 2016;16(3):291-301. doi: 10.1517/14712598.2016.1134479. Epub 2016 Feb 6. PubMed |
9. | Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Author: Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW. Journal: Expert Opin Biol Ther. 2016 Jul;16(7):859-71. doi: 10.1517/14712598.2016.1170804. Epub 2016 Apr 12. PubMed |
10. | Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer. Author: Yang J, Chen J, Wei J, Liu X, Cho WC. Journal: Expert Opin Biol Ther. 2016 Jul 18. [Epub ahead of print] PubMed |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室